US Stock MarketDetailed Quotes
CLCS CELL SOURCE INC
- 0.000200
- -0.397800-99.95%
15min DelayClose Apr 19 16:00 ET
7.71KMarket Cap-1P/E (TTM)
0.000200High0.000200Low1.00KVolume0.000200Open0.398000Pre Close0.20Turnover0.00%Turnover RatioLossP/E (Static)38.55MShares0.74000052wk High0.00P/B6.54KFloat Cap0.00020052wk Low--Dividend TTM32.71MShs Float2.250000Historical High--Div YieldTTM0.00%Amplitude0.000200Historical Low0.000000Avg Price1Lot Size
About CELL SOURCE INC Company
Cell Source, Inc. operates as a cell therapy company focused on immunotherapy. Its Veto Cell technology is a next generation immunotherapy technology that enables the selective attenuation of the immune system. The company's Veto Cell platform roadmap consists of two main programs: VETO CAR-T (with and without HSCT) and Veto Cell Organ Transplantation. The company was founded on June 6, 2012 and is headquartered in New York, NY.
Company Profile
SymbolCLCS
Company NameCELL SOURCE INC
Founded2012
CEOMr. Itamar Shimrat
MarketPink Market
Employees1
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address57 West 57th Street,Suite 400
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10019
Phone1-646-416-7896
Websitehttp://www.cell-source.com
Company Executives
- Name
- Position
- Salary
- Itamar Shimrat
- Chief Executive Officer, Chief Accounting Officer, Chief Financial Officer and Director
- 165.63K
- Dennis Brown
- Chairman of the Board
- --
- David Zolty
- Director
- --
- Ben Friedman
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg